{"filing":{"accession_number":"0001213900-26-091756","cik":"0001840425","ticker":"OSRHW","company_name":"OSR Health, Inc.","form":"8-K","filing_date":"2026-08-19","report_date":"2026-08-19","primary_document":"ea0302782-8k_osrhealth.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840425/000121390026091756/ea0302782-8k_osrhealth.htm"},"events":[{"id":28602,"run_id":26170,"accession_number":"0001213900-26-091756","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"OSR Health received a Staff Delisting Determination from Nasdaq on August 19, 2026, notifying the company that its common stock and warrants will be delisted from the Nasdaq Capital Market due to failure to maintain the minimum $1.00 closing bid price required by Nasdaq Listing Rule 5550(a)(2). Trading suspension is scheduled for August 26, 2026, with formal delisting to follow unless the company successfully appeals to the Nasdaq Hearings Panel.","company_name":"OSR Health, Inc.","ticker":"OSRHW","filing_date":"2026-08-19","form":"8-K","submitted_at":null,"items":[{"id":30599,"accession_number":"0001213900-26-091756","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"OSR Health received a Staff Delisting Determination from Nasdaq on August 19, 2026, notifying the company that its common stock and warrants will be delisted from the Nasdaq Capital Market due to failure to maintain the minimum $1.00 closing bid price required by Nasdaq Listing Rule 5550(a)(2). Trading suspension is scheduled for August 26, 2026, with formal delisting to follow unless the company successfully appeals to the Nasdaq Hearings Panel. This is a direct notice of delisting risk under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:07:03.239119+00:00","company_name":"","ticker":null,"filing_date":""},{"id":30600,"accession_number":"0001213900-26-091756","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"OSR Health disclosed receipt of a Staff Delisting Determination from Nasdaq notifying the company that its common stock and warrants are subject to delisting due to failure to maintain the minimum bid price requirement. Trading suspension is scheduled for August 26, 2026. The company intends to request a hearing before the Nasdaq Independent Hearings Panel to appeal the determination. This is a clear delisting risk disclosure under Item 3.01 equivalent, disclosed via Item 7.01 Regulation FD Disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:07:03.239119+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30599,"accession_number":"0001213900-26-091756","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"OSR Health received a Staff Delisting Determination from Nasdaq on August 19, 2026, notifying the company that its common stock and warrants will be delisted from the Nasdaq Capital Market due to failure to maintain the minimum $1.00 closing bid price required by Nasdaq Listing Rule 5550(a)(2). Trading suspension is scheduled for August 26, 2026, with formal delisting to follow unless the company successfully appeals to the Nasdaq Hearings Panel. This is a direct notice of delisting risk under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:07:03.239119+00:00","company_name":"OSR Health, Inc.","ticker":"OSRHW","filing_date":"2026-08-19"},{"id":30600,"accession_number":"0001213900-26-091756","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"OSR Health disclosed receipt of a Staff Delisting Determination from Nasdaq notifying the company that its common stock and warrants are subject to delisting due to failure to maintain the minimum bid price requirement. Trading suspension is scheduled for August 26, 2026. The company intends to request a hearing before the Nasdaq Independent Hearings Panel to appeal the determination. This is a clear delisting risk disclosure under Item 3.01 equivalent, disclosed via Item 7.01 Regulation FD Disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:07:03.239119+00:00","company_name":"OSR Health, Inc.","ticker":"OSRHW","filing_date":"2026-08-19"}]}